European journal of human genetics : EJHG · 2020
NGS-based spinal muscular atrophy carrier screening of 10,585 diverse couples in China: a pan-ethnic study.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhao Sumin, Wang Wanyang, Wang Yaoshen, Han Rui, Fan Chunna, Ni Peixiang, Guo Fengyu, Zeng Fanwei, Yang Qiaona, Yang Yun, Sun Yan, Zhang Xinhua, Chen Yan, Zhu Baosheng, Cai Wangwei, Chen Shaoke, Cai Ren, Guo Xiaoling, Zhang Chonglin, Zhou Yuqiu, Huang Shuodan, Liu Yanhui, Chen Biyan, Yan Shanhuo, Chen Yajun, Ding Hongmei, Shang Xuan, Xu Xiangmin, Sun Jun, Peng Zhiyu
Аннотация
In this study, we performed a spinal muscular atrophy carrier screening investigation with NGS-based method. First, the validation for NGS-based method was implemented in 2255 samples using real-time PCR. The concordance between the NGS-based method and real-time PCR for the detection of SMA carrier and patient were up to 100%. Then, we applied this NGS-based method in 10,585 self-reported normal couples (34 Chinese ethnic groups from 5 provinces in South China) for SMA carrier screening. The overall carrier frequency was 1 in 73.8 (1.4%). It varied substantially between ethnic groups, highest in Dai ethnicity (4.3%), and no significant difference was found between five provinces. One couple was detected as carriers with an elevated risk of having an SMA affected baby. The distribution of SMN1:SMN2 genotype was also revealed in this study. Among the individuals with normal phenotype, the exon 7 copy-number ratio of SMN1 to SMN2 proved the gene conversion between them. With NGS-based method, we investigated SMA carrier status in Chinese population for the first time, and our results demonstrated that it is a promising alternative for SMA carrier screening and could provide data support and reference for future clinical application.